Activity Preview


State Targeted Response: Opioid Use Disorder: Treatment Considerations

Activity Type:

  • On Demand Plus

Release Date: 1/7/2019

Expiration Date: 6/22/2019

  • AMA PRA Category 1: 12
  • Participation: 12



This 12-week virtual learning collaborative will provide an overview of the treatment options available for patients with opioid use disorder. Treatment considerations will be discussed with detail given to special populations and overdose prevention. This collaborative will provide evidence-based research to address issues surrounding the use of medication-assisted treatment.   

If you'd like to join us on this learning experience, please fill out the form at

This activity is supported by the States Targeted Response (STR) Technical Assistance (TA) Consortium

Funding for this initiative was made possible (in part) by grant no. 1H79TI080816-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


This activity is available by invitation only and a Group ID is required to enroll. Please enter the code you received by email to unlock the activity. If you have misplaced your Group ID, please contact  

Educational Objectives

  • Identify the basic epidemiology and describe the magnitude of opioid use disorder
  • Analyze basic information about the common medications used to treat opioid use disorder
  • Classify basic harm reduction strategies including the role of naloxone in opioid overdose prevention
  • Summarize a broad overview of the primary psychosocial treatment options for opioid use disorder

Target Audience

Psychiatrists who want to develop a more in-depth understanding of the available treatment options for medication-assisted treatment (MAT) to help address the lack of adequate access to care for patients with opioid use disorder and substance abuse disorder. 

Estimated Time to Complete

Estimated Duration: 12 weeks; 12 hours
Program Begin Date: January 28, 2019
Program End Date: April 22, 2019
Credit Claim End Date: June 22, 2019

(Note: This is a 12-week scheduled course that runs from January 28, 2019 to April 22, 2019. Credit must be claimed within 60 days post-event)

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit ™ or a certificate of participation may do so by completing all sections of the course including the evaluation. A multiple choice quiz is provided based on the content. A passing score of 70% must be achieved. Retakes are available for the test. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the date of completion and hours earned.

Continuing Education Credit

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring CME activity for a maximum of 12 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures

Program Presenter

  • Brian Fuerhlein, M.D., PhD, Assistant Professor of Psychiatry; Director, Psychiatric Emergency Room, VA Connecticut Healthcare System. Reports no financial relationships with commercial interests.

Program Planners

  • Tristan Gorrindo, MD, Director, Division of Education, American Psychiatric Association. Reports no financial relationships with commercial interests.
  • Eunice Maize, Project Manager, STR Grant, American Psychiatric Association. Reports no financial relationships with commercial interests.

Hardware/Software Requirements

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:

  • Flash Player: Adobe Flash Player 10.3+ 
  • Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
  • Operating System: Windows XP+ or Mac OS X 10.4+ 
  • Internet Connection: 1 Mbps or higher

Minimum Requirements:

  • Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
  • Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content

For assistance: Contact for questions about this activity | Contact for technical assistance